paraganglioma
FDA Approves Welireg for Pheochromocytoma and Paraganglioma
The FDA approved belzutifan (Welireg, Merck) for adult and pediatric patients aged 12 years and older with locally ...
MAY 20, 2025
FDA Approves Azedra for Patients With Rare Adrenal Cancers
The FDA approved iobenguane I 131 (Azedra, Progenics)—the first treatment for patients with rare, ...
JULY 31, 2018
Load more